Introduction
============

The spinal cord is the main channel for motor and sensory conduction between the brain and body.^[@bib1]^ Spinal cord injury (SCI), prevalent in young patients, is one of the most common diseases worldwide with a high incidence, a high disability rate and a high cost for treatment.^[@bib2]^ SCI is characterized by neuron and oligodendrocyte loss, demyelination, axonal injury and axonal myelination disorder, resulting in sensation loss associated with hemiplegia or paralysis.^[@bib3]^ Currently, vehicle crashes are the leading cause of SCI, followed by falls, acts of violence (mainly gunshot wounds) and sports/recreational activities.^[@bib4]^ Conventional therapy, cell transplantation and gene therapy are the main therapies used for treating SCI. For cell transplantation, bone marrow mesenchymal stem cells (BMSCs) are transplantable cells that are easily obtained and have no immune rejection reaction. Gene therapy can be used to import neurotrophic factors into the body and promote SCI recovery.^[@bib5],\ [@bib6]^ The regulation of microRNAs (miRs) in gene therapy has attracted more and more attention in recent years, and it may provide a new target for SCI treatment.^[@bib7]^

As non-coding small-molecule RNAs, miRs can regulate gene expression.^[@bib8]^ miR-124 is widely expressed in the mature mammalian brain and is also one of the earliest discovered highly conserved miRs; it plays an important role in the process of neurogenesis.^[@bib9],\ [@bib10]^ Xu *et al.*^[@bib11]^ reported that the expression of miR-124 is associated with BMSCs and spinal cord stem cells, which have an important influence on functional restoration after SCI. Mesenchymal stem cells (MSCs), characterized by multi-potent differentiation, are a stem cell type found in the bone marrow (BM) and other tissues.^[@bib12]^ BMSCs are a type of hematopoietic stem cell in the BM that has a high degree of self-renewal and differentiation potential.^[@bib13]^ There are many advantages in the application of stem cells, especially for BMSCs, which simultaneously repair cartilage and bone with positive effects and contribute to the reconstruction and integration of the host surface.^[@bib14]^ BMSC transplantation provides a new direction for SCI treatment, which was first performed in a rat model of SCI.^[@bib15]^ As there were relatively scarce reports on the mechanism of *miR-124* gene-modified BMSC transplantation for the repair of SCI, this study aims to explore the effects of lentivirus-mediated *miR-124* gene-modified BMSC transplantation on the repair of SCI in rats in order to provide targets for the treatment of SCI.

Materials and methods
=====================

Ethic statement
---------------

This study was performed in accordance with the animal ethics standards and with approval of the animal ethics committee at Shanghai Jiao Tong University Affiliated Sixth People\'s Hospital. All the procedures used in our animal experiments were in accordance with the standard of experimental animal management and protection principles.

Isolation and identification of BMSCs
-------------------------------------

Rats were anesthetized with an intra-peritoneal injection of ketamine (60 mg kg^−1^) at first. Their four limbs were removed after iodine disinfection. The bone marrow cavity was exposed with an incision in the metaphysis and rinsed with phosphate-buffered saline (PBS) until the fluid was clear. The bone marrow cell suspension was prepared, followed by centrifugation at 1500 r.p.m. for 5 min. It was then re-suspended in Dulbecco\'s modified Eagle\'s medium (DMEM) containing 10% fetal bovine serum (FBS), 100 U ml^−1^ of penicillin and 100 mg ml^−1^ of streptomycin. The cells were cultured in DMEM at 37 °C, 5% CO~2~ and saturated humidity. The medium was changed for the first time after 3 days, and non-adherent cells were discarded. Thereafter, the medium was changed every 2 days until cells reached a high confluence. Then, the cells were passaged and cryopreserved after trypsin digestion. The cells were rinsed twice with PBS, and 0.25% trypsin was added to adjust the density to 10^5^ ml^−1^. Then, after the addition of fluorescent-labeled antibodies (anti-rat CD29/CD34/CD44/CD45 antibodies from Abcam, Cambridge, MA, USA), the cells were incubated in the dark for 30 min at 4 °C. After centrifugation at 200 *g*, the cell debris were re-suspended in PBS, and the surface markers for BMSCs (cells positive for CD29, CD34, CD44 and CD45) were identified using a flow cytometer (Beckton Dickinson, BD Bioscience, San Jose, CA, USA).

Construction and identification of the recombinant lentiviral vector
--------------------------------------------------------------------

Polymerase chain reaction (PCR) amplification was applied to obtain DNA fragments containing the miR-124 sequences in rats (100 bp upstream and downstream sequences). The DNA fragments obtained from PCR were inserted into the H1-MCS-CMV-EGFP vector and sequenced using dual-enzyme digestion with *Xho*I and *Bam*HI. The PCR conditions were 5 min of pre-denaturation at 95 °C; 25 reaction cycles of 30 s denaturation at 95 °C, 30 s annealing at 58 °C and 30 s extension at 72 °C; followed by 5 min of final extension at 72 °C. The PCR primer sequences were as follows: forward: 5′-TCGTTAAGGCACGCGGTG-3′ reverse: 5′-GTGCAGGGTCCGAGGT-3′. The 293T cells were co-transfected with the recombinant lentiviral vector and two auxiliary packaging plasmids (pHelper1.0 and pHelper2.0), followed by cell culture for 48 h. Then, the supernatant was collected from the cells and filtered through a 0.45-μm membrane. Finally, the recombinant lentiviral vector containing miR-124 (miR-124-LV) and the recombinant lentiviral vector containing the green fluorescent protein (GFP) reporter gene (NC-EGFP-LV) were obtained. The virus titer of the cells was determined using a gradient dilution method in a 24-well plate. At first, 293T cells were seeded into the 24-well plate at a density of 1 × 10^5^ cells per well. After the cells were cultured for 24 h, the virus-containing fluid (50 μl) was serially diluted at gradient proportions (ranging from 10^−1^ to 10^−6^) as required. Each concentration of the fluid was added to three wells for transfection. Forty-eight hours after transfection, the diluted concentration of cells that was \~10% of the GFP expression frequency was selected for later experiments. The number of GFP positive cells and the virus titer were measured for cells at this concentration using the following calculation: virus titer (BT=TU ml^−1^) TU μl^−1^=(*P* × *N*/100 × *V*) × 1/DF (*P*=GFP positive cells, *N*=10^5^, *V*=virus fluid volume=50 μl, DF=dilution proportion).

The recombinant lentiviral vector was transfected into BMSCs in the logarithmic phase of growth (multiplicity of infection (MOI)=20). Three days after the transfection, 4′,6-diamidino-2-phenylindole (DAPI) staining was implemented for 1 h. Then, the expression of the lentivirus reporter gene GFP was observed under a fluorescence microscope, and the cells were sub-cultured for subsequent experiments when the transfection efficiency \>95%.

Construction and identification of the *PDXK*-siRNA (si-*PDXK*) plasmid
-----------------------------------------------------------------------

On the basis of the published pyridoxal kinase (PDXK) mRNA sequence (GenBank: NM 031769.1) and siRNA design principles, the DNA template for the target gene was synthesized with the online software provided by the Promega Corporation (Madison, WI, USA), followed by *in vitro* transcription. Thus, the final si-*PDXK* plasmid was obtained. Once the siRNA efficiency in BMSCs was observed to be higher than 85% with an effective duration time of 4--10 days, the si-*PDXK* plasmid was identified as viable and was reserved for later experiments. The sequence of the positive-sense strand was 5′-GCAAACAAUGUCAACAAGU dTdT-3′ and that of the antisense strand 3′-dTdT CGUUUGUUACAGUUGUUCA-5′. Then, the BMSCs were transfected with the si-*PDXK* plasmid using Lipofectamine 2000 (Lip2000; Invitrogen, Carlsbad, CA, USA).

Luciferase-reporter gene assay
------------------------------

The target gene of miR-124 was predicted by the online software Targetscan 7.1 (<http://www.targetscan.org/vert_71/>). DNA fragments containing the miR-124-binding site in the 3′-untranslated regions (3′-UTR) of *PDXK* and fragments containing the mutant miR-27a-binding site were separately inserted into the luciferase reporter gene plasmid to obtain the *PDXK*-WT (wild type) and *PDXK*-MUT (mutant type) plasmids, respectively. Afterwards, the miR-124 mimics and *PDXK*-WT/*PDXK*-MUT plasmids were co-transfected into 293T cells, and the luciferase activities of the transfected cells were detected using luciferase assay. In addition, 293T cells were co-transfected with a negative control (NC) oligonucleotide and *PDXK*-WT/*PDXK*-MUT plasmids as control.

A rat model of SCI
------------------

Seventy-two specific pathogen-free (SPF) Sprague-Dawley (SD) rats between 2 and 3 months of age, and weighing \~200--250 g, were purchased from Shanghai Biomodel Organism Science & Technology Co. The improved Allen method was applied to construct the SCI model. A hitting device was placed on a stereotaxic apparatus. After the T10 spinal cord was exposed, a circular thin copper gasket (diameter=3 mm, area=7 mm^2^, weight=0.1 g) was placed on the surface of the T10 spinal cord. A weight of 10 g fell free onto the gasket to cause SCI. The amount of the injury was set as 10 *g*·5 cm. A sham operation (sham) group was used as the control, and T10 spinal cord was exposed in the same way without SCI. All 72 SD rats were randomly divided into six groups. In the blank group (*n*=12), rats were administered 100 μl of sterile saline using a microsyringe via the tail vein. In the sham group, rats underwent a sham operation of SCI and were administered 100 μl of sterile saline using a microsyringe via the tail vein. In the SCI group, rats were administered 100 μl of sterile saline using a microsyringe via the tail vein of rats 1 day after the success of the SCI model. In the negative control (NC) group, rats were administered 2 × 10^6^ per 100 μl of sterile saline and transplanted with BMSCs that were transfected with the NC-EGFP-LV vector through a microsyringe 1 day after the success of the SCI model. In the overexpressed miR-124 group (*n*=12), rats were administered with 2 × 10^6^ per 100 μl of sterile saline and transplanted with BMSCs that were transfected with the miR-124-LV vector through a microsyringe 1 day after the success of the SCI model. In the si-*PDXK* group, rats were administered with 2 × 10^6^ per 100 μl of sterile saline and transplanted with BMSCs that were transfected with the si-*PDXK* plasmid.

Quantitative real-time polymerase chain reaction
------------------------------------------------

Thirty-five days after the BMSCs were transplanted into rats, injured spinal cord tissue homogenate was extracted from the rats. The total RNA was extracted from the tissues using an RNAiso Plus Kit (Takara Biotechnology, Dalian, Liaoning, China). The PrimeScript RT reagent kit (Takara Biotechnology) was applied for reverse transcription. The quantitative real-time polymerase chain reaction was conducted using a SteponePlus (Applied Biosystems, Grand Island, NY, USA) PCR instrument. The PCR reaction volumes contained 1.6 μl of cDNA solution, 5 μl of 2 × SYBR Green Taq PCR mix (Takara Biotechnology), 0.2 μl of PCR forward primer and 0.2 μl of reverse primer (both at 10 μ[M]{.smallcaps}) and 3 μl of double distilled water. The PCR reaction conditions were as follows: 5 min pre-denaturation at 95 °C; 60 cycles of 10 s denaturation at 95 °C, 10 s annealing at 58 °C, and extension 10 s; followed by a final 10 min extension at 72 °C. With β-actin (Gene ID 2597) selected as the internal reference, the PDXK and miR-124 mRNA expression was detected using the 2^−ΔΔCt^ method. The primer sequences are shown in [Table 1](#tbl1){ref-type="table"}.

Western blotting
----------------

The injured spinal cord tissues were extracted 35 days after the BMSCs were transplanted into rats. The tissue homogenate was obtained using Radio-Immunoprecipitation Assay (RIPA) lysis buffer (Gibco, Grand Island, NY, USA) and protease inhibitors (Sigma-Aldrich Chemical Company, St Louis, MO, USA) that were added to tissues, followed by centrifugation (12 000 *g* for 10 min) at 4 °C. The supernatant was then extracted as protein samples, and the protein concentration of these samples was detected using a bicinchoninic acid (BCA) kit (Bio-Rad Laboratories, CA, USA). After detection, the samples were preserved at −80 °C. Western blotting was performed using 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis with the addition of 20 μg of protein from each sample into each well. After the primary antibody against anti-PDXK (sc-50961, 1:200, Santa Cruz Biotechnology, CA, USA) was added, the protein samples were preserved overnight at 4 °C. A peroxidase (POD)-conjugated goat anti-rabbit (1:5000) antibody was used as the secondary antibody. It was added to the samples, and this was followed by culture for 30 min at room temperature. Horseradish peroxidase (HRP; Bio-Rad Laboratories) was added to the samples for color development. ImageQuant 350 and ImageQuant TL-1 (GE Healthcare, Fairfield, CT, USA) were applied for band analysis of the protein samples. The protein β-actin was used as the internal reference, and the gray-scale ratio of the target protein and β-actin was represented as the relative protein expression.

Basso, Beattie and Bresnahan scale
----------------------------------

The Basso, Beattie and Bresnahan (BBB) scale was used to assess the locomotor capacity following SCI after 24 h of spinal cord contusion and at 7, 21 and 35 days after the transplantation of BMSCs. Assessments of four aspects were conducted, including limb joint performance, paw placement, toe clearance and the overall behavioral performance.^[@bib16]^

Immunohistochemistry
--------------------

The extracted spinal cord tissues were rinsed with PBS three times, fixed with 4% paraformaldehyde, embedded in paraffin and finally sliced into sections. Then, the tissue sections were stained using immunohistochemistry. After dewaxing and rehydration, 3% hydrogen peroxide was added to the sections for 15 min to block the endogenous peroxidase activity, followed by antigen retrieval with 30 min steam-heating. After that, the tissues were sealed in PBS containing 1% bovine serum albumin for 1 h at room temperature, and the samples were incubated for 30 min at room temperature with the addition of the primary antibodies, followed by an overnight incubation at 4 °C. The primary antibodies included those against neuron-specific enolase (NSE, ab53025; 1:250; Abcam), neurofilament (NF, ab7795; 1:200; Abcam) and microtubule-associated protein 2 (MAP2, ab5392; 1:250; Abcam), which were added to the tissue sections together with the antibody against bromodeoxyuridine (BrdU, ab6326; 1:250; Abcam). Then, the tissues were rinsed with PBS three times (3 min per time), and the POD-conjugated goat anti-rabbit (1:5000) secondary antibody was added dropwise. The sections were finally preserved at room temperature for 30 min. Then, they were rinsed with PBS three times (3 min per time) and HRP (Bio-Rad Laboratories) was added to the sections for color development. After this, the sections were subjected to hematoxylin counter-staining, alcohol dehydration and mounting with neutral gum. The stained tissues were observed under a microscope and photographed at × 400 magnification. Ten fields were randomly selected to measure the densities of the double-labeled positive cells (BrdU+NSE, BrdU+NF, BrdU+MAP2) and the BrdU-positive cells (cell per mm^3^). The ratio of the BrdU-positive cells/nerve cell marker-positive cells to the BrdU-positive cells/nerve cell marker-negative cells was calculated.

Enzyme-linked immunosorbent assay
---------------------------------

Injured tissues were collected and rinsed with PBS 3 times, and the tissue homogenate was prepared with the addition of RIPA lysis buffer (Gibco, Grand Island, NY, USA) and protease inhibitors (Sigma-Aldrich Chemical Company, St. Louis, MO, USA). Then, the homogenate was centrifuged (12000 × *g*) for 10 min at 4 °C, and the supernatant was extracted as protein samples. The expression of the SCI repair-related proteins was detected using ELISA kits (R&D Systems, Minneapolis, MN, USA) containing thyrotropin-releasing hormone (TRH), prostacyclin (PGI2) and gangliosides (GM).

Statistical analysis
--------------------

SPSS 20.0 software (SPSS, Chicago, IL, USA) was applied for statistical analysis, and the measurement data are represented as the mean±s.d. (). Comparisons between two groups were analyzed using a *t*-test. A one-way analysis of variance was used for comparisons among multiple groups, and the least significant difference method was implemented with pairwise comparisons. *P*\<0.05 was considered statistically significant.

Results
=======

Morphological characteristics and surface markers of BMSCs after *in vitro* culture
-----------------------------------------------------------------------------------

The cell morphology of BMSCs after *in vitro* culture and subculture (three generations) was in accordance with the morphological characteristics of BMSCs. BMSCs were observed as macromonocytes in various forms with fusiform, polygonal or star-like neurites, and the cells were present as single cells or multiple-cell clones with rapid cell proliferation after 3--7 days of primary culture. Ten days after the primary culture, fusiform BMSCs were observed and reached a high confluence ([Figure 1](#fig1){ref-type="fig"}). Flow cytometry was applied to detect the surface markers for BMSCs. The results showed that the percentages of positive CD29, CD44, CD34 and CD45 cells were 88.75%, 75.39%, 1.11% and 0.71%, respectively, which were all in compliance with the typical BMSC characteristics ([Figure 2](#fig2){ref-type="fig"}). These results confirmed that BMSCs were successfully isolated from rats and cultured.

Transfection efficiency of the recombinant lentiviral vector
------------------------------------------------------------

GFP-positive cells were detected at 72 h after the BMSCs were transfected with the recombinant lentivirus vector. The percentage of GFP-positive cells was higher than 95%, which shows that the transfection was successful ([Figure 3](#fig3){ref-type="fig"}).

miR-124 targets *PDXK*, as identified by a luciferase assay
-----------------------------------------------------------

Shown as [Figure 4](#fig4){ref-type="fig"}, the Targetscan software identified that *PDXK* was the target gene of miR-124. miR-124 mimics had no effect on the luciferase activity of 293T cells with *PDXK*-MUT. However, the luciferase activity of the cells with NC+*PDXK*-WT was significantly higher than that of the cells with miR-124 mimics+*PDXK*-WT (*P*\<0.05). Thus, the miR-124 mimics decrease the luciferase activity of cells with *PDXK*-WT.

Comparisons of the mRNA expression of miR-124 and PDXK mRNA among the blank, sham, SCI, NC, overexpressed miR-124 and si-*PDXK* groups
--------------------------------------------------------------------------------------------------------------------------------------

The mRNA expression levels of miR-124 and PDXK detected by quantitative real-time polymerase chain reaction are shown in [Figure 5](#fig5){ref-type="fig"}. The miR-124 mRNA expression levels in the SCI, NC and si-*PDXK* groups were significantly decreased in comparison to the blank and sham groups (all *P*\<0.05), and the miR-124 mRNA expression levels in the NC and si-*PDXK* groups were markedly higher than that in the SCI group (both *P*\<0.05). The overexpressed miR-124 group exhibited a significantly higher miR-124 mRNA expression than the SCI and NC groups (both *P*\<0.05), but it was not notably different compared with the blank and the sham groups (both *P*\>0.05). PDXK mRNA expression levels in the SCI and NC groups were significantly elevated in comparison to the blank and sham groups (all *P*\<0.05), and the SCI group had a higher PDXK mRNA expression than the NC group (*P*\<0.05). The mRNA expression of PDXK in the overexpressed miR-124 group was significantly lower than that of the SCI and NC groups (both *P*\<0.05). However, no significant difference was observed in the overexpressed miR-124 group compared with the blank and sham groups (both *P*\>0.05). These results indicated that the overexpression of miR-124 inhibited the expression of PDXK.

Comparison of the PDXK protein expression among the blank, sham, SCI, NC, overexpressed miR-124 and si-*PDXK* groups
--------------------------------------------------------------------------------------------------------------------

The protein expression of PDXK detected by western blotting is shown in [Figure 6](#fig6){ref-type="fig"}. Compared with the blank and sham groups, the PDXK protein expression levels in the SCI and NC groups were significantly increased (both *P*\<0.05), and the SCI group showed a higher PDXK protein expression level than the NC group (*P*\<0.05). In addition, the PDXK protein expression levels in the overexpressed miR-124 and si-*PDXK* groups were significantly lower compared with the SCI and NC groups (both *P*\<0.05). However, the PDXK protein expression levels in the overexpressed miR-124 and si-*PDXK* groups were similar to those of the blank and the sham groups (*P*\>0.05). These results further demonstrated that the overexpression of miR-124 inhibited the expression of PDXK.

Comparison of the BBB scores at different time points among the blank, sham, SCI, NC, overexpressed miR-124 and si-*PDXK* groups
--------------------------------------------------------------------------------------------------------------------------------

The BBB scores are presented in [Table 2](#tbl2){ref-type="table"}. Twenty-four hours after being injured, the BBB scores in the SCI, NC, overexpressed miR-124 and si-*PDXK* groups were significantly lower than that in the blank and sham groups (all *P*\<0.05). In addition, 7 days and 24 days after the BMSCs were transplanted into rats, the BBB scores in the NC and overexpressed miR-124 groups were significantly increased in comparison to that of the SCI group (all *P*\<0.05), and the overexpressed miR-124 group had a remarkably higher BBB score than the NC group (*P*\<0.05). Moreover, 35 days after transplantation, the BBB scores in the SCI and NC groups were significantly reduced compared to those of the blank and sham groups (all *P*\<0.05), and no significant differences were observed among the BBB scores of the overexpressed miR-124, the blank and sham groups (all *P*\>0.05). The experimental results above showed that miR-124 overexpression or *PDXK* gene silencing improved the ability of BMSCs to repair SCI.

Comparison of nerve cell markers and BrdU-positive cells among the blank, sham, SCI, NC, overexpressed miR-124 and si-*PDXK* groups
-----------------------------------------------------------------------------------------------------------------------------------

On 35th day after SCI, the results showed that no BrdU-positive cells were observed in the blank, sham and SCI groups, but BrdU-positive cells were observed in the overexpressed miR-124, NC and si-*PDXK* groups. In addition, the double-labeled positive cell density (BrdU+NSE, BrdU+NF and BrdU+MAP2), the BrdU-positive cell density and the ratio of BrdU-positive cells/nerve cell marker-positive cells to BrdU-positive cells/nerve cell marker-negative cells in the overexpressed miR-124 group were significantly higher than those of the NC group (all *P*\<0.05) ([Figure 7](#fig7){ref-type="fig"}). Thus, miR-124 overexpression or *PDXK* gene silencing may enhance the differentiation of BMSCs into neurocytes.

Comparisons of protein expression levels of SCI repair-related proteins among the blank, sham, SCI, NC, overexpressed miR-124 and si-*PDXK* groups
--------------------------------------------------------------------------------------------------------------------------------------------------

The protein expression levels of TRH, PGI2 and GM in the NC group were significantly higher than those in the SCI group (all *P*\<0.05), and the protein expression levels of TRH, PGI2 and GM in the overexpressed miR-124 group were significantly increased compared with the NC group (all *P*\<0.05) ([Figure 8](#fig8){ref-type="fig"}). These results indicated that miR-124 overexpression or *PDXK* gene silencing increased the expression of SCI repair-related proteins, including TRH, PGI2 and GM.

Discussion
==========

The mechanism of miR-124-modified BMSC transplantation in the repair of SCI in rats was investigated in a rat model of SCI. This study found that miR-124 accelerated the differentiation of BMSCs into neurocytes and promoted the repair of SCI. Thus, miR-124 is expected to become a new target for SCI treatment.

Our study found that there was a significant decrease in the miR-124 expression in the SCI group. miR-124 is expressed in both the immature and mature neurons of the nervous system, and is relatively abundant in the brain, retina and spinal cord neurons; it is also critical in neural development and differentiation.^[@bib17]^ A decrease in the level of miR-124 was observed in the brain and spinal cord tissues of mice after SCI, and its expression may reflect the severity of SCI.^[@bib18]^ A study by Nakanishi *et al.*^[@bib19]^ discovered that miR-124a was specifically expressed in the central nervous system, but there was a significant reduction in the miR-124a expression in rats with SCI, which was consistent with this study. In addition, the protein expression levels of PDXK in the overexpressed miR-124 and si-*PDXK* groups were significantly lower when compared with the SCI and NC groups, indicating that the overexpression of miR-124 inhibited the expression of PDXK. PDXK is capable of catalyzing the phosphorylation of vitamin B6, resulting in its active form, pyridoxal phosphate; it participates in the salvage synthesis pathway of pyridoxal phosphate in order to maintain the normal physiological function of the central nervous system. Metabolic disorder of PDXK activity can result in metabolic disorder of amino acids, which may be the pathogenesis of the secondary injury of nervous system and other neurological damage.^[@bib20],\ [@bib21]^ PDXK is distributed in the cytoplasm of spinal cord neurons and glial cells, which maintain the dynamic equilibrium of the pyridoxal phosphate concentration to restore stability of the SCI microenvironment, and PDXK is also the target protein for miR-124 to inhibit.^[@bib22]^ Therefore, it was found that miR-124 was a negative regulator of PDXK, and it conferred an inhibitory effect on PDXK expression. Consistent with this finding, the luciferase activity of cells treated with NC+*PDXK*-WT was significantly higher than that of the cells treated with miR-124 mimics+*PDXK*-WT. In addition, the Targetscan software indicated that *PDXK* was the target gene of miR-124. However, the specific mechanism of the regulation of PDXK by miR-124 requires further research.

The current study also found that the BBB scores were significantly increased in the overexpressed miR-124 and si-PDXK groups compared with the SCI group at 7, 21 and 35 days after transplantation. The BBB scale has been widely used to evaluate the functional recovery of rats after SCI.^[@bib23]^ In the overexpressed miR-124 and si-*PDXK* groups, a few necrotic neurons in the spinal cord gray matter, the complete axonal structure in the white matter axonal and the clear lamellar structure in the myelin were observed. These results confirmed that miR-124 overexpression or *PDXK* gene silencing improved the ability of BMSCs to repair injured spinal cord tissues.

In addition, the double-labeled positive cell density (BrdU+NSE, BrdU+NF or BrdU+MAP2), the BrdU-positive cell density and the ratio of BrdU-positive cells/nerve cell marker-positive cells to the BrdU-positive cells/nerve cell marker-negative cells in the overexpressed miR-124 group were significantly higher than those in the NC group. NSE, NF and MAP2 are neuronal markers involved in neuronal differentiation, and they have been used to assess the differentiation of BMSC into neuronal cells.^[@bib24],\ [@bib25]^ Thus, miR-124 overexpression could enhance the differentiation of BMSCs into neurons. The miR-124 in neural stem cells (NSCs) could promote NSC differentiation into neurons and astrocytes, which could fill the cleaved neurons and astrocytes in the damaged area. NSCs could also secrete a variety of neurological nutritional factors needed for SCI repair, which is conducive to improving the environment and the restoration of functional recovery after SCI.^[@bib11]^ Thus, miR-124 might improve the differentiation competence of BMSCs into neurocytes, which thereby could enhance the capability of BMSCs to repair SCI. NSCs could construct new synaptic connections by connecting SCI ends, secrete neurotrophic factors in the injured area, improve the damaged spinal microenvironment, and promote the remyelination and recovery of nerve conduction to repair SCI.^[@bib26]^ miRNAs could mediate the neural differentiation of stem cells, and the brain-specific miR miR-124 is considered to be a mediator of neurogenesis.^[@bib27]^ Importantly, miR-124 may be associated with the differentiation of BMSCs in that the overexpression of miR-124 promotes the differentiation of BMSCs into neurons.^[@bib28]^ In addition, the inhibition of miR-124 would not only reduce the neuronal differentiation efficiency of BMSCs but also reduce cell viability.^[@bib29]^ For further comprehension of this role, our study also detected the protein expression levels of SCI repair-related proteins (TRH, PGI2 and GM). The expression levels of these proteins in the overexpressed miR-124 group were significantly higher than those of the NC and SCI groups. Several studies have proposed that the association of TRH, PGI2 and GM with SCI could contribute to the possible treatments.^[@bib30],\ [@bib31],\ [@bib32]^ However, the explanation of the detailed mechanism for this association is limited, and more studies are required in the future.

In conclusion, this study demonstrates that miR-124 accelerates the differentiation ability of BMSCs into neurocytes, thereby promoting the repair of spinal cord tissues after SCI. This finding may provide a new target for SCI therapy. The overexpression of miR-124 inhibited the expression of PDXK, which could be a possible mechanism for how miR-124 promotes the differentiation of BMSCs. However, further research of this mechanism is required, and the role of miR-124 downstream signaling pathways requires further study.
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![The cell morphology of BMSCs after *in vitro* culture and subculture (× 200). (**a**) The cell morphology of BMSCs 3 days after the primary culture. (**b**) The cell morphology of BMSCs 7 days after the primary culture. BMSCs, bone marrow mesenchymal stem cells.](emm201748f1){#fig1}

![The positive rates of the surface markers (CD29, CD44, CD34 and CD45) of BMSCs detected by flow cytometry. BMSCs, bone marrow mesenchymal stem cells.](emm201748f2){#fig2}

![The transfection efficacy of recombinant lentiviral vector in BMSCs. (**a**) The fluorescence image of BMSCs transfected with miR-124-LV or NC-EGFP-LV. (**b**) A comparison of the rate of EGFP-positive cells (transfection efficacy) between BMSCs transfected with miR-124-LV or NC-EGFP-LV. BMSCs, bone marrow mesenchymal stem cells; miR-124, microRNA-124; miR-124-LV, the recombinant lentiviral vector containing the miR-124 gene; NC-EGFP-LV, the recombinant lentiviral vector containing green fluorescent protein reporter gene.](emm201748f3){#fig3}

![The identification of *PDXK* as the target gene of miR-124 using a luciferase reporter gene assay. (**a**) The identification of *PDXK* as the target gene of miR-124 using the online software Targetscan 7.1. (**b**) A comparison of the luciferase activity among cells transfected with *PDXK*-WT/*PDXK*-MUT+NC oligonucleotide or *PDXK*-WT/*PDXK*-MUT+miR-124 mimics. miR-124, microRNA-124; MUT, mutant type; NC, negative control; WT, wild type. \**P*\<0.05 compared with cells transfected with *PDXK*-WT+NC oligonucleotide.](emm201748f4){#fig4}

![Comparisons of the mRNA expression of miR-124 and PDXK among the blank, sham, SCI, NC, overexpressed miR-124 and si-*PDXK* groups. miR-124, microRNA-124; NC, negative control; SCI, spinal cord injury; si-*PDXK*, *PDXK*-siRNAs. \**P*\<0.05 compared with the blank group; ^\#^*P*\<0.05 compared with the sham group; ^&^*P*\<0.05 compared with the SCI group *P*\<0.05; ^\$^*P*\<0.05 compared with the NC group.](emm201748f5){#fig5}

![A comparison of the PDXK protein expression among the blank, sham, SCI, NC, overexpressed miR-124 and si-*PDXK* groups. (**a**) The band analysis of the PDXK protein expression among the blank, sham, SCI, NC, overexpressed miR-124 and si-PDXK groups detected by western blotting. (**b**) A comparison of the PDXK protein expression among the blank, sham, SCI, NC, overexpressed miR-124 and si-*PDXK* groups. miR-124, microRNA-124; NC, negative control; PDXK, pyridoxal kinase; SCI, spinal cord injury; si-*PDXK*, *PDXK*-siRNAs. \**P*\<0.05 compared with the blank group; ^\#^*P*\<0.05 compared with the sham group; ^&^*P*\<0.05 compared with the SCI group; ^\$^*P*\<0.05 compared with the NC group.](emm201748f6){#fig6}

![Comparisons of the nerve cell markers and BrdU-positive cells among the NC, overexpressed miR-124 and si-PDXK groups. (**a**) Double-labeled positive cells (BrdU+NSE, BrdU+NF and BrdU+MAP2) detected by immunohistochemistry among the NC, overexpressed miR-124 and si-*PDXK* groups. (**b**) A comparison of the double-labeled positive cell density (BrdU+NSE, BrdU+NF and BrdU+MAP2) among the NC, overexpressed miR-124 and si-*PDXK* groups. (**c**) A comparison of the BrdU-positive cell density among the NC, overexpressed miR-124 and si-*PDXK* groups. (**d**) A comparison of the ratio of BrdU-positive cells/nerve cell marker-positive cells to the BrdU-positive cells/nerve cell marker-negative cells among the NC, overexpressed miR-124 and si-*PDXK* groups. BrdU, bromodeoxyuridine; MAP2, microtubule-associated protein 2; miR-124, microRNA-124; NC, negative control; NF, neurofilament; NSE, neuron-specific enolase; si-*PDXK*, *PDXK*-siRNAs. \**P*\<0.05 compared with the NC group.](emm201748f7){#fig7}

![Comparisons of the protein expression levels of SCI repair-related proteins among the blank, sham, SCI, NC, overexpressed miR-124 and si-*PDXK* groups. miR-124, microRNA-124; NC, negative control; SCI, spinal cord injury; si-*PDXK*, *PDXK*-siRNAs. \**P*\<0.05 compared with the blank group; ^\#^*P*\<0.05 compared with the sham group; ^&^*P*\<0.05 compared with the SCI group; ^\$^*P*\<0.05 compared with the NC group.](emm201748f8){#fig8}

###### Primer sequences for quantitative real-time polymerase chain reaction

  ----------- -------------------------------
  *Gene*      *Primer sequence*
  *PDXK*      F: 5′-AGACATTATCACGCCCAACC-3′
              R: 5′-CCAGTGCCCACAAAGACG-3′
  *miR-124*   F: 5′-TCGTTAAGGCACGCGGTG-3′
              R: 5′-GTGCAGGGTCCGAGGT-3′
  *β-actin*   F: 5′-TGGGACGACATGGAGAAAA-3′
              R: 5′-CTGGAAGGTGGACAGCGAG-3′
  ----------- -------------------------------

Abbreviations: F, forward; R, reverse.

###### Comparison of BBB scores at different time points among the blank, sham, SCI, NC, overexpressed miR-124 and si-PDXK groups

  *Time point*                   *Blank group*   *Sham group*   *SCI group*                                                          *NC group*                                                                                        *Overexpressed miR-124 group*                                                                                                 *si-PDXK group*
  ------------------------------ --------------- -------------- -------------------------------------------------------------------- ------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------- -----------------------------------------------------------------------------------------------------------------------------
  24 Hours after being injured   16.75±1.98      15.98±2.17     2.86±0.95^[a](#t2-fn2){ref-type="fn"},[b](#t2-fn3){ref-type="fn"}^   3.15±1.01^[a](#t2-fn2){ref-type="fn"},[b](#t2-fn3){ref-type="fn"}^                                2.53±0.56^[a](#t2-fn2){ref-type="fn"},[b](#t2-fn3){ref-type="fn"}^                                                            2.69±0.62^[a](#t2-fn2){ref-type="fn"},[b](#t2-fn3){ref-type="fn"}^
  7 Days after inoculation       17.01±2.39      16.19±2.11     5.26±1.38^[a](#t2-fn2){ref-type="fn"},[b](#t2-fn3){ref-type="fn"}^   8.25±1.87^[a](#t2-fn2){ref-type="fn"},[b](#t2-fn3){ref-type="fn"},[c](#t2-fn4){ref-type="fn"}^    10.76±2.31^[a](#t2-fn2){ref-type="fn"},[b](#t2-fn3){ref-type="fn"},[c](#t2-fn4){ref-type="fn"},[d](#t2-fn5){ref-type="fn"}^   11.28±2.55^[a](#t2-fn2){ref-type="fn"},[b](#t2-fn3){ref-type="fn"},[c](#t2-fn4){ref-type="fn"},[d](#t2-fn5){ref-type="fn"}^
  21 Days after inoculation      18.11±2.36      16.52±2.15     4.83±1.12^[a](#t2-fn2){ref-type="fn"},[b](#t2-fn3){ref-type="fn"}^   9.02±1.75^[a](#t2-fn2){ref-type="fn"},[b](#t2-fn3){ref-type="fn"},[c](#t2-fn4){ref-type="fn"}^    12.99±2.51^[a](#t2-fn2){ref-type="fn"},[b](#t2-fn3){ref-type="fn"},[c](#t2-fn4){ref-type="fn"},[d](#t2-fn5){ref-type="fn"}^   13.41±2.87^[a](#t2-fn2){ref-type="fn"},[b](#t2-fn3){ref-type="fn"},[c](#t2-fn4){ref-type="fn"},[d](#t2-fn5){ref-type="fn"}^
  35 Days after inoculation      18.34±2.43      18.27±2.61     6.95±1.08^[a](#t2-fn2){ref-type="fn"},[b](#t2-fn3){ref-type="fn"}^   12.37±1.31^[a](#t2-fn2){ref-type="fn"},[b](#t2-fn3){ref-type="fn"},[c](#t2-fn4){ref-type="fn"}^   17.55±2.42^[c](#t2-fn4){ref-type="fn"},[d](#t2-fn5){ref-type="fn"}^                                                           17.94±2.36^[c](#t2-fn4){ref-type="fn"},[d](#t2-fn5){ref-type="fn"}^

Abbreviations: BBB, Basso, Beattie and Bresnahan; miR-124, microRNA-124; NC, negative control; SCI, spinal cord injury; si-*PDXK*, *PDXK*-siRNA.

*P*\<0.05 compared with the blank group at the same time point.

*P*\<0.05 compared with the sham group at the same time point.

*P*\<0.05 compared with the SCI group at the same time point.

*P*\<0.05 compared with the NC group at the same time point.

[^1]: These authors contributed equally to this work.
